WisdomTree Global Quality Dividend Growth UCITS ETF - USD Acc is a equity ETF from WisdomTree tracking the Global Quality Dividend Growth index through physical replication. Domiciled in Ireland and launched in 2016, the fund manages about 649 M € and charges a TER of 0.38% — 38 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
WisdomTree Global Quality Dividend Growth UCITS ETF - USD Acc competes with 1 other products on the same index (Global Quality Dividend Growth): it ranks 1st by fund size and 1st by ongoing cost, with a TER of 0.38% against a group median of 0.38%. It has been listed since 2016, 10 years of track record.
On a €10,000 investment the TER costs 38 € a year, and no product in the group costs less.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 26.3% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in USD. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
Irish domicile lets the fund apply the Ireland–US tax treaty, with 15% withholding instead of 30% on US dividends received by the fund.
| Apple Inc. | 3.9% |
| Microsoft Corporation | 3.3% |
| AbbVie Inc | 2.8% |
| Broadcom Inc | 2.7% |
| Merck & Company Inc | 2.5% |
| The Coca-Cola Company | 2.5% |
| Cisco Systems Inc | 2.3% |
| NVIDIA Corporation | 2.2% |
| UnitedHealth Group Incorporated | 2.1% |
| Toyota Motor Corp | 2.0% |
| Borsa Italiana | GGRA | EUR |
| XETRA | WTEM | EUR |
| London Stock Exchange | GGRG | GBX |
| London Stock Exchange | GGRA | USD |
| Euronext Paris | GGRA | EUR |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.